Never miss a Delaware County story!
Marinus Pharmaceuticals of Radnor saw its stock price plunge by more than 80 percent Monday because of a setback in an experimental seizure drug, writes…
ArriVent Biopharma in Newtown Square plans to initiate a public stock offering to raise between $137.5 million and $160 million for the development and…
Radnor-based Brodie Generational Capital Partners has bought the assets of Cytimmune Sciences, a medical research company based in Rockville, Maryland and is relocating it…
It works out that Delaware County opioid payments and payments for other counties in Pennsylvania run an average of $6.50 per resident, but the…
The Nobel Prize in Medicine has been announced and it is being awarded to Dr. Katalin Karikó and Dr. Drew Weissman, writes Benjamin Mueller and…
A Berwyn-based biopharmaceutical company is filing for a patent for its new drug candidate that could potentially treat neurodegenerative diseases. Annovis Bio filed for…
Laboratory product and services provider Avantor, located in Radnor, has started a global “responsible supplier’ program to help reduce the environmental impact and accelerate sustainable…
Swiss biopharmaceutical company Idorsia Ltd. has entered into negotiations to operate in the Asia Pacific region and gain licensing rights there for its products, writes…
NRx Pharmaceuticals in Radnor has signed a licensing deal for its new drug candidate targeting bipolar depression, writes John George for Philadelphia Business Journal.
The…
Two Delaware County life science firms are leading the way this year in equity financing.
A cancer treatment drug being developed by ArriVent Biopharma in…
A Villanova University associate professor of chemical engineering is researching whether earthworm hemoglobin can one day replace human blood as donor blood for trauma care…
A public stock offering from Mineralys Therapeutics of Radnor netted $192 million for the company’s development of a new blood pressure drug candidate, lorundrostat…
Mineralys Therapeutics, a Radnor biopharmaceutical company is hoping to raise $100 million to develop a new high blood pressure treatment, writes John George for Philadelphia…
A Newtown Square biopharmaceutical company, ArriVent, has raised $110 million in a private stock sale to bring cancer medicines approved in China to the U…
Emergent BioSolutions Inc., based in Radnor, has come up with an over-the-counter version of Narcan Nasal Spray, writes Julie Wernau for The Wall…
Before we send you to this site, please subscribe to our daily newsletter.